Followers | 167 |
Posts | 35823 |
Boards Moderated | 3 |
Alias Born | 10/20/2019 |
Wednesday, July 21, 2021 2:40:09 PM
In addition, FPC iron is delivered regardless of other underlying conditions which might otherwise block the release of iron. Some of the challenges of managing iron in sick patients, including inflammation, hepcidin block, and functional iron deficiency, can be overcome with FPC due to its ability to provide bioavailable iron.
FPC is highly soluble in water and, therefore, can be formulated for parenteral administration either by the dialysis solution or intravenously. As a result, this novel approach to iron management has the potential for application in the treatment of anemia in many disease states.
Recent RMTI News
- Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States • Business Wire • 04/17/2024 10:00:00 AM
- Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024 • Business Wire • 04/16/2024 10:00:00 AM
- Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda • Business Wire • 04/04/2024 10:00:00 AM
- Rockwell Medical Named 'Great Place to Work' for Second Year in a Row • Business Wire • 03/25/2024 10:00:00 AM
- Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023 • Business Wire • 03/21/2024 10:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:31:02 PM
- Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024 • Business Wire • 02/08/2024 11:00:00 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:56:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:36:07 PM
- Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund • Business Wire • 01/08/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 11:52:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 11:15:54 AM
- Rockwell Medical Announces Third Quarter 2023 Results • Business Wire • 11/14/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 10:18:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 10:17:25 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 10:16:39 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 10:16:02 AM
- Rockwell Medical Names Jesse Neri as Senior Vice President, Finance • Business Wire • 10/18/2023 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 10:15:59 AM
- Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors • Business Wire • 10/17/2023 10:00:00 AM
- Rockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023 • Business Wire • 10/16/2023 10:00:00 AM
- Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care • Business Wire • 10/03/2023 10:00:00 AM
- Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into Utah • Business Wire • 09/28/2023 10:00:00 AM
- Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024 • Business Wire • 09/21/2023 10:30:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM